New Delhi [India], May 2 (ANI): Since the onset of global coronavirus pandemic, scientists, experts and medical practitioners are vigorously engaged in researching for the most effective treatment of COVID-19 patients. As per the experts, antiviral drug -- Remdesivir -- could be the answe
California [USA], May 2 (ANI): US-based biopharmaceutical major Gilead Sciences said that the US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for investigational anti-viral remdesivir to treat COVID-19.
Washington D.C. [US], May 2 (Sputnik/ANI): The US Food and Drug Administration has authorized an emergency use of Remdesivir drug in coronavirus treatment, FDA head Stephen Hahn announced on Friday.
Mumbai (Maharashtra) [India], April 30 (ANI): Equity benchmark indices advanced on Thursday in line with global cues as positive results for experimental remdesivir drug towards COVID-19 treatment lifted investor sentiment.
Washington D.C. [US], April 30 (ANI): A preliminary data analysis from NIH clinical trial shows that hospitalized patients with "advanced COVID-19 and lung involvement who received the investigational antiviral remdesivir recovered faster than similar patients who received placebo".
New Delhi [India], April 18 (ANI): The Indian Council of Medical Research (ICMR) on Saturday said it is conducting "observational study" on hydroxychloroquine (HCQ).
Washington D.C. [USA], Mar 20 (ANI): As experts from across the world scramble to find a cure for the deadly COVID-19, a few pre-existing drugs have shown positive signs in treating the fast-spreading disease.